700 related articles for article (PubMed ID: 33531979)
1. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
2. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
4. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Wang M; Li C; Liu Y; Wang Z
Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
[TBL] [Abstract][Full Text] [Related]
5. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
7. Identification of
Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
Front Genet; 2022; 13():810292. PubMed ID: 35368661
[TBL] [Abstract][Full Text] [Related]
8. ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer.
Zhang T; Yu S; Zhao S
PeerJ; 2021; 9():e12605. PubMed ID: 35003923
[TBL] [Abstract][Full Text] [Related]
9. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
Zhu H; Wang G; Zhu H; Xu A
J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
[No Abstract] [Full Text] [Related]
10. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer.
Lin T; Peng W; Mai P; Zhang E; Peng L
Front Mol Biosci; 2021; 8():626966. PubMed ID: 34113647
[TBL] [Abstract][Full Text] [Related]
11. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
12. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
13. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
16. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
Wang D; Wang QH; Luo T; Jia W; Wang J
World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
[TBL] [Abstract][Full Text] [Related]
17. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
Fang W; Wan D; Yu Y; Zhang L
Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
[TBL] [Abstract][Full Text] [Related]
18. High expression of
Lin B; Zhang T; Ye X; Yang H
Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
[TBL] [Abstract][Full Text] [Related]
19. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
[TBL] [Abstract][Full Text] [Related]
20. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]